INSIDER · CIK 1801917
Venker Eric
President & Immunovant CEO at Roivant Sciences Ltd. (ROIV) · Chief Executive Officer, Director at Immunovant, Inc. (IMVT)
↗9 Form 4 rows in the window
Covers original filings from Jul 31, 2026 to Oct 28, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$21.6MSold on the market
2Companies
Oct 22, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 202618:44 | Oct 20, 2026 | ROIVRoivant Sciences Ltd. | President & Immunovant CEO | S · Sell10b5-1 | $35.11 | −200,000 | 1,399,154 | -13% | −$7.0M | ||
| Oct 5, 202619:42 | Oct 2, 2026 | IMVTImmunovant, Inc. | Chief Executive Officer, Director | S · Sell | $34.11 | −3,506 | 257,075 | -1% | −$120K | ||
| Oct 5, 202619:42 | Oct 1, 2026 | IMVTImmunovant, Inc. | Chief Executive Officer, Director | M · Exercise | $14.46 | +92,187 | 346,467 | +36% | $1.3M | ||
| Oct 5, 202619:42 | Oct 1, 2026 | IMVTImmunovant, Inc. | Chief Executive Officer, Director | D · To issuer | $33.65 | −85,886 | 260,581 | -25% | $2.9M | ||
| Oct 2, 202617:37 | Sep 30, 2026 | ROIVRoivant Sciences Ltd. | President & Immunovant CEO | S · Sell10b5-1 | $36.62 | −200,000 | 1,599,154 | -11% | −$7.3M | ||
| Oct 2, 202617:37 | Sep 30, 2026 | ROIVRoivant Sciences Ltd. | President & Immunovant CEO | M · Exercise10b5-1 | $3.85 | +200,000 | 1,799,154 | +13% | $770K | ||
| Sep 1, 202621:00 | Aug 28, 2026 | ROIVRoivant Sciences Ltd. | President & Immunovant CEO | S · Sell10b5-1 | $35.77 | −200,000 | 1,599,154 | -11% | −$7.2M | ||
| Sep 1, 202621:00 | Aug 28, 2026 | ROIVRoivant Sciences Ltd. | President & Immunovant CEO | M · Exercise10b5-1 | $3.85 | +200,000 | 1,799,154 | +13% | $770K | ||
| Aug 24, 202621:00 | Aug 20, 2026 | ROIVRoivant Sciences Ltd. | President & Immunovant CEO | F · Tax | $36.84 | −13,909 | 1,599,154 | -1% | $512K |